Mechanisms for Muscarinic Inhibition of Somatostatin Release From Canine Fundic D Cells

Metabolism: Clinical and Experimental - Netherlands
doi 10.1016/0026-0495(90)90228-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Haloperidol, a Dopaminergic Antagonist: Somatostatin-Like Inhibition of Glucagon and Insulin Release From the Isolated, Perfused Canine Pancreas

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1978English

Prostaglandin E2 Production by Dispersed Canine Fundic Mucosal Cells. Contribution of Macrophages and Endothelial Cells as Major Sources.

Journal of Clinical Investigation
Medicine
1989English

In Vitro Simultaneous Release of Endogenous Somatostatin and Growth Hormone From Human Adenomatous Pituitary Cells

Pediatric Research
Child HealthPediatricsPerinatology
1986English

Flow-Mediated Release of Nitric Oxide From Lymphatic Endothelial Cells of Pressurized Canine Thoracic Duct.

The Japanese Journal of Physiology
2003English

Molecular Mechanisms of Somatostatin Receptor Trafficking

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2011English

Axonal Mechanisms Mediating GABA-A Receptor Inhibition of Striatal Dopamine Release

2020English

Intracellular Calcium in Canine Cultured Tracheal Smooth Muscle Cells Is Regulated by M3 Muscarinic Receptors

British Journal of Pharmacology
Pharmacology
1993English

Stimulation of Immunoreactive Somatostatin Release From Hypothalamic Synaptosomes by High (K+) and Dopamine.

Endocrinologia Japonica
1977English

Transglutaminase Inhibition: Possible Therapeutic Mechanisms to Protect Cells From Death in Neurological Disorders `

2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy